Loading clinical trials...
Loading clinical trials...
A Phase 1/2, Dose Escalation and Expansion Trial to Evaluate the Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Conditions
Interventions
Tegavivint
Locations
1
United States
Clinical Trials Nurse Navigator
Scottsdale, Arizona, United States
Start Date
February 17, 2026
Primary Completion Date
January 1, 2029
Completion Date
July 1, 2029
Last Updated
March 11, 2026
NCT07536113
NCT07228832
NCT07321106
NCT06719206
NCT07224724
NCT07237438
Lead Sponsor
HonorHealth Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions